Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Health Resources and Services Administration
 Periodically, the Health Resources and Services Administration (HRSA) publishes abstracts of information collection requests under review by the Office of Management and Budget (OMB), in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request a copy of the clearance requests submitted to OMB for review, e-mail 
                    *paperwork@hrsa.gov*
                     or call the HRSA Reports Clearance Office on (301) 443-1129. The following request has been submitted to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995: Proposed Project: Enrollment and Re-Certification of Entities in the 340B Drug Pricing Program [NEW] Section 602 of Public Law 102-585, the Veterans Health Care Act of 1992, enacted section 340B of the Public Health Service Act (PHS Act) “Limitation on Prices of Drugs Purchased by Covered Entities.” Section 340B provides that a manufacturer who sells covered outpatient drugs to eligible entities must sign a pharmaceutical pricing agreement with the Secretary of Health and Human Services in which the manufacturer agrees to charge a price for covered outpatient drugs that will not exceed an amount determined under a statutory formula. Covered entities which choose to participate in the section 340B Drug Pricing Program must comply with the requirements of 340B(a)(5) of the PHS Act. Section 340B(a)(5)(A) prohibits a covered entity from accepting a discount for a drug that would also generate a Medicaid rebate. Further, section 340B(a)(5)(B) prohibits a covered entity from reselling or otherwise transferring a discounted drug to a person who is not a patient of the entity. In response to the statutory mandate of section 340B(a)(9) to notify manufacturers of the identities of covered entities and the mandate of section 340B(a)(5)(A)(ii) to establish a mechanism to ensure against duplicate discounts and the ongoing responsibility to administer the 340B Drug Pricing Program while maintaining efficiency, transparency and integrity, the HRSA Office of Pharmacy Affairs (OPA) developed a process of registration of covered entities to enable it to address those mandates. Enrollment/Registration To enroll and certify the eligible federally funded grantees and other safety net health care providers, OPA requires entities to submit administrative information (
                    *e.g.*, shipping and billing arrangements, Medicaid participation), certifying information and signatures from appropriate grantee level or entity level authorizing officials and State/local government representatives. The purpose of this registration information 
                    ( print page 40822)
                    is to determine eligibility for the 340B program. This information is received and verified according to 340B requirements and entered into the 340B database. Accurate records are critical to implementation of the 340B legislation especially to prevent diversion and duplicate discounts. To maintain accurate records, the OPA requests entities to submit modifications to any administrative information that they submitted when initially enrolling into the program. The burden requirement for these processes is minimal. Contract Pharmacy Self-Certification In order to ensure that drug manufacturers and drug wholesalers recognize contract pharmacy arrangements, covered entities that elect to utilize a contract pharmacy are required to submit to OPA a self-certification form similar to the registration form that they have signed an agreement with the contract pharmacy. The Estimates of annualized burden are as follows: Reporting requirement
Number of
                             respondents
Responses per
                             respondent
Total
                             responses
Hours per
                             response
Total burden
                             hours**DSH & Children's Hospital Enrollment, Additions & Recertifications**340B Program Registrations & Certifications for Disproportionate Share Hospitals
70
1
70
.25
17.5340B Program Registrations & Certifications for Children's Hospitals
80
1
80
.25
20Certifications to Enroll DSH & Children's Hospitals Outpatient facilities to 340B Program
180
1
180
.083
14.94DSH & Children's Hospitals' Annual Recertification
937
1
937
.5
468.5**Registration for Entities Other Than Hospitals & Recertifications**340B Registration Form (Family Planning, STD, TB, and others)
170
1
170
.083
14.11Family Planning Annual Recertification
85
47
3995
.083
331.59STD & TB Annual Recertification
111
11
1221
.083
101.34Other Entity Annual Recertification for entities other than DSHs, FP, STD or TB entities
400
10
4000
.083
332Submission of Administrative Changes for any entity
460
1
460
.083
38.18**Contracted Pharmacy Services Registration & Recertifications**Contracted Pharmacy Services Registration
2000
1
2000
.083
166Total
* 4493

13,313

1504.16* The total number of respondents may be overestimated since we are unable to avoid duplication of respondents who submit information to the OPA over the course of participation in the 340B Drug Pricing Program, via the initial registration process to any updates/modifications and enrolling contract pharmacies, if applicable, to the recertification process.
 Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this notice to the desk officer for HRSA, either by e-mail to 
                    *OIRA_submission@omb.eop.gov*
                     or by fax to 202-395-6974. Please direct all correspondence to the “attention of the desk officer for HRSA.” Dated: August 5, 2009. Alexandra Huttinger, Director, Division of Policy Review and Coordination.


[FR Doc. E9-19381 Filed 8-12-09; 8:45 am] BILLING CODE 4165-15-P